Skip to main content
Top
Published in: Infection 3/2018

01-06-2018 | Case Report

Vacuum-assisted closure therapy of paradoxical reaction in tuberculous lymphadenopathy caused by Mycobacterium africanum

Authors: H. F. Geerdes-Fenge, P. Pongratz, J. Liese, E. C. Reisinger

Published in: Infection | Issue 3/2018

Login to get access

Abstract

A 26-year-old HIV-negative male from Ghana was treated for cervical, intrathoracic and abdominal lymph node tuberculosis (TB) and tuberculous hepatitis. Penetration of the thoracic trachea by a mediastinal lymph node had caused bronchomucosal TB. Sputum culture grew M. africanum, sensitive to all first-line antituberculous drugs. Four weeks after the beginning of directly observed treatment with isoniazid, rifampin, pyrazinamide and ethambutol, the right cervical lymph node increased in size, liquefied and caused a spontaneous fistula. A biopsy of the necrotized lymph node revealed rare acid-fast bacilli with a positive PCR for Mycobacterium tuberculosis complex. After debridement, vacuum-assisted closure therapy was performed for 6 weeks. Five months after the beginning of antituberculous therapy, a second paradoxical reaction occurred, with painful swelling of two contralateral supraclavicular lymph nodes. Extirpation of one node yielded a positive PCR for M. tuberculosis complex; the culture was negative. Antituberculous treatment was continued, and additional treatment with oral prednisolone 20 mg daily for 1 month tapering over 10 weeks was introduced, resulting in a decrease in lymphadenopathy. Antituberculous treatment was continued for a total of 9 months. The outcome was favorable, no further lymphadenopathy occurred over the following 6 months.
Literature
1.
go back to reference Peto HM, Pratt RH, Harrington TA, LoBue PA, Armstrong LR. Epidemiology of extrapulmonary tuberculosis in the United States, 1993–2006. Clin Infect Dis. 2009;49:1350–7.CrossRefPubMed Peto HM, Pratt RH, Harrington TA, LoBue PA, Armstrong LR. Epidemiology of extrapulmonary tuberculosis in the United States, 1993–2006. Clin Infect Dis. 2009;49:1350–7.CrossRefPubMed
2.
go back to reference Brodhun B, Altmann D, Hauer B, Fiebig L, Haas W. Bericht zur Epidemiologie der Tuberkulose in Deutschland für 2015. Berlin: Robert Koch-Institut; 2016. Brodhun B, Altmann D, Hauer B, Fiebig L, Haas W. Bericht zur Epidemiologie der Tuberkulose in Deutschland für 2015. Berlin: Robert Koch-Institut; 2016.
3.
4.
go back to reference Geri G, Passeron A, Heym B, Arlet JB, Pouchot J, Capron L, Ranque B. Paradoxical reactions during treatment of tuberculosis with extrapulmonary manifestations in HIV-negative patients. Infection. 2013;41:537–43.CrossRefPubMed Geri G, Passeron A, Heym B, Arlet JB, Pouchot J, Capron L, Ranque B. Paradoxical reactions during treatment of tuberculosis with extrapulmonary manifestations in HIV-negative patients. Infection. 2013;41:537–43.CrossRefPubMed
5.
go back to reference de Jong BC, Antonio M, Gagneux S. Mycobacterium africanum–review of an important cause of human tuberculosis in West Africa. PLoS Negl Trop Dis. 2010;4:e744.CrossRefPubMedPubMedCentral de Jong BC, Antonio M, Gagneux S. Mycobacterium africanum–review of an important cause of human tuberculosis in West Africa. PLoS Negl Trop Dis. 2010;4:e744.CrossRefPubMedPubMedCentral
6.
go back to reference Trauner M, Grasmug E, Stauber RE, Hammer HF, Hoefler G, Reisinger EC. Recurrent Salmonella enteritidis sepsis and hepatic tuberculosis. Gut. 1995;37:136–9.CrossRefPubMedPubMedCentral Trauner M, Grasmug E, Stauber RE, Hammer HF, Hoefler G, Reisinger EC. Recurrent Salmonella enteritidis sepsis and hepatic tuberculosis. Gut. 1995;37:136–9.CrossRefPubMedPubMedCentral
7.
go back to reference Bell LC, Breen R, Miller RF, Noursadeghi M, Lipman M. Paradoxical reactions and immune reconstitution inflammatory syndrome in tuberculosis. Int J Infect Dis. 2015;32:39–45.CrossRefPubMed Bell LC, Breen R, Miller RF, Noursadeghi M, Lipman M. Paradoxical reactions and immune reconstitution inflammatory syndrome in tuberculosis. Int J Infect Dis. 2015;32:39–45.CrossRefPubMed
8.
go back to reference Breen RA, Smith CJ, Bettinson H, Dart S, Bannister B, Johnson MA, Lipman MC. Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection. Thorax. 2004;59:704–7.CrossRefPubMedPubMedCentral Breen RA, Smith CJ, Bettinson H, Dart S, Bannister B, Johnson MA, Lipman MC. Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection. Thorax. 2004;59:704–7.CrossRefPubMedPubMedCentral
9.
go back to reference Brown CS, Smith CJ, MacCormick Breen RA, Ormerod LP, Mittal R, Fisk M, Milburn HJ, Price NM, Bothamley GH, Lipman MCI. Determinants of treatment-related paradoxical reactions during anti-tuberculosis therapy: a case control study. BMC Infect Dis. 2016;16:479.CrossRefPubMedPubMedCentral Brown CS, Smith CJ, MacCormick Breen RA, Ormerod LP, Mittal R, Fisk M, Milburn HJ, Price NM, Bothamley GH, Lipman MCI. Determinants of treatment-related paradoxical reactions during anti-tuberculosis therapy: a case control study. BMC Infect Dis. 2016;16:479.CrossRefPubMedPubMedCentral
10.
go back to reference Cho OH, Park KH, Kim T, Song EH, Jang EY, Lee EJ, Chong YP, Choi SH, Lee SO, Woo JH, Kim YS, Kim SH. Paradoxical responses in non-HIV-infected patients with peripheral lymph node tuberculosis. J Infect. 2009;59:56–61.CrossRefPubMed Cho OH, Park KH, Kim T, Song EH, Jang EY, Lee EJ, Chong YP, Choi SH, Lee SO, Woo JH, Kim YS, Kim SH. Paradoxical responses in non-HIV-infected patients with peripheral lymph node tuberculosis. J Infect. 2009;59:56–61.CrossRefPubMed
11.
go back to reference Chahed H, Hachicha H, Berriche A, Abdelmalek R, Mediouni A, Kilani B, Amor MB, Benaissa HT, Besbes G. Paradoxical reaction associated with cervical lymph node tuberculosis: predictive factors and therapeutic management. Int J Infect Dis. 2017;54:4–7.CrossRefPubMed Chahed H, Hachicha H, Berriche A, Abdelmalek R, Mediouni A, Kilani B, Amor MB, Benaissa HT, Besbes G. Paradoxical reaction associated with cervical lymph node tuberculosis: predictive factors and therapeutic management. Int J Infect Dis. 2017;54:4–7.CrossRefPubMed
12.
go back to reference Strady C, Brochot P, Ainine K, Jegou J, Remy G, Eschard JP, Jaussaud R. Tuberculose lors d’un traitement par agents inhibiteurs du TNF alpha. Presse Med. 2006;35:1765–72.CrossRefPubMed Strady C, Brochot P, Ainine K, Jegou J, Remy G, Eschard JP, Jaussaud R. Tuberculose lors d’un traitement par agents inhibiteurs du TNF alpha. Presse Med. 2006;35:1765–72.CrossRefPubMed
13.
go back to reference Barr DA, Coussens AK, Irvine S, Ritchie ND, Herbert K, Choo-Kang B, Raeside D, Bell DJ, Seaton RA. Paradoxical upgrading reaction in extra-pulmonary tuberculosis: association with vitamin D therapy. Int J Tuberc Lung Dis. 2017;21:677–83.CrossRefPubMedPubMedCentral Barr DA, Coussens AK, Irvine S, Ritchie ND, Herbert K, Choo-Kang B, Raeside D, Bell DJ, Seaton RA. Paradoxical upgrading reaction in extra-pulmonary tuberculosis: association with vitamin D therapy. Int J Tuberc Lung Dis. 2017;21:677–83.CrossRefPubMedPubMedCentral
14.
go back to reference Cheng VC, Ho PL, Lee RA, Chan KS, Chan KK, Woo PC, Lau SK, Yuen KY. Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis. 2002;21:803–9.CrossRefPubMed Cheng VC, Ho PL, Lee RA, Chan KS, Chan KK, Woo PC, Lau SK, Yuen KY. Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis. 2002;21:803–9.CrossRefPubMed
15.
go back to reference Bunkar ML, Agnihotri SP, Gupta PR, Arya S. Add-on prednisolone in the management of cervical lymph node tuberculosis. Indian J Tuberc. 2016;63:96–9.CrossRefPubMed Bunkar ML, Agnihotri SP, Gupta PR, Arya S. Add-on prednisolone in the management of cervical lymph node tuberculosis. Indian J Tuberc. 2016;63:96–9.CrossRefPubMed
16.
go back to reference Kolloli A, Subbian S. Host-directed therapeutic strategies for tuberculosis. Front Med (Lausanne). 2017;4:171.CrossRef Kolloli A, Subbian S. Host-directed therapeutic strategies for tuberculosis. Front Med (Lausanne). 2017;4:171.CrossRef
17.
go back to reference Fontanilla JM, Barnes A, von Reyn CF. Current diagnosis and management of peripheral tuberculous lymphadenitis. Clin Infect Dis. 2011;53:555–62.CrossRefPubMed Fontanilla JM, Barnes A, von Reyn CF. Current diagnosis and management of peripheral tuberculous lymphadenitis. Clin Infect Dis. 2011;53:555–62.CrossRefPubMed
18.
go back to reference Fleischmann W, Becker U, Bischoff M, Hoekstra H. Vacuum sealing: indication, technique, and results. Eur J Orthop Surg Traumatol. 1995;5:37–40.CrossRefPubMed Fleischmann W, Becker U, Bischoff M, Hoekstra H. Vacuum sealing: indication, technique, and results. Eur J Orthop Surg Traumatol. 1995;5:37–40.CrossRefPubMed
19.
go back to reference Luo X, Tang X, Ma Y, Zhang Y, Fang S. The efficacy of negative pressure wound therapy in treating sacroiliac joint tuberculosis with a chronic sinus tract: a case series. J Orthop Surg Res. 2015;10:120.CrossRefPubMedPubMedCentral Luo X, Tang X, Ma Y, Zhang Y, Fang S. The efficacy of negative pressure wound therapy in treating sacroiliac joint tuberculosis with a chronic sinus tract: a case series. J Orthop Surg Res. 2015;10:120.CrossRefPubMedPubMedCentral
Metadata
Title
Vacuum-assisted closure therapy of paradoxical reaction in tuberculous lymphadenopathy caused by Mycobacterium africanum
Authors
H. F. Geerdes-Fenge
P. Pongratz
J. Liese
E. C. Reisinger
Publication date
01-06-2018
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 3/2018
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-017-1112-2

Other articles of this Issue 3/2018

Infection 3/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.